InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
8
T+90 hit rate
50%
T+90 mean return
-25.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by RALLIS CHRIS A, Director. Officer active across 1 company, notably Fennec Pharmaceuticals INC.. In total, 22 reports have been published. Split: 0 buy · 8 sells. Total volume traded: €75k. History available since 21 October 2021. The latest transaction was disclosed on 10 October 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations22 total
4,062 shares@ US$1.23Common SharesSEC:0001185945-25-000005:0
2,127 shares@ US$2.352.5% of flowCommon SharesSEC:0001415889-25-019433:0
2,173 shares@ US$2.302.7% of flowCommon SharesSEC:0001415889-25-010574:0
1,992 shares@ US$2.512.9% of flowCommon SharesSEC:0001415889-25-004249:0
10,000 shares@ US$2.6915.2% of flowCommon SharesSEC:0001415889-24-028018:0
1,960 shares@ US$2.552.7% of flowCommon SharesSEC:0001415889-24-024986:0
1,792 shares@ US$2.792.8% of flowCommon SharesSEC:0001415889-24-019332:0
800 shares@ US$10.454.7% of flowCommon SharesSEC:0001415889-24-010817:0
2,114 shares@ US$10.9712.8% of flowCommon SharesSEC:0001415889-24-009205:0
1,390 shares@ US$10.908.2% of flowCommon SharesSEC:0001104659-23-130042:0
269 shares@ US$8.251.2% of flowCommon SharesSEC:0001415889-23-015314:0
673 shares@ US$7.852.9% of flowCommon SharesSEC:0001415889-23-012411:0
16,666 shares@ US$0.726.5% of flowCommon SharesSEC:0001415889-23-011416:0
2,207 shares@ US$8.4710.3% of flowCommon SharesSEC:0001415889-23-010905:0
833 shares@ US$7.363.4% of flowCommon SharesSEC:0001415889-23-008417:0
1,700 shares@ US$2.942.7% of flowCommon SharesSEC:0001415889-23-006577:0
4,166 shares@ US$2.405.6% of flowCommon SharesSEC:0001415889-23-004182:0
333 shares@ US$7.991.5% of flowCommon SharesSEC:0001415889-22-011492:0
4,762 shares@ US$1.053.1% of flowCommon SharesSEC:0001415889-22-010738:0
11,111 shares@ US$0.452.9% of flowCommon SharesSEC:0001104659-22-080585:0
8,333 shares@ US$0.600.0017% mcap34.9% of flowCommon SharesSEC:0001104659-22-031286:0
3,333 shares@ US$1.500.0016% mcap32.6% of flowCommon SharesSEC:0001104659-21-128430:0
22 of 22 declarations
About RALLIS CHRIS A
Chris A. Rallis is a Board Member of Fennec Pharmaceuticals Inc., where he contributes to the governance and strategy of the company. His experience in the pharmaceutical sector is valuable to the board, allowing him to make informed decisions.
